Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Peter C. Black, Kim E. van Kessel et al.|European Urology|2017Cited by 793
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Peter C. Black, Ewan A. Gibb et al.|Clinical Cancer Research|2018Cited by 126
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder CancerKim E.M. van Kessel, Joost L. Boormans, Lorraine M. de Haan et al.|Bladder Cancer|2016Cited by 30